Terlipressin as a first choice in septic shock-not yet.

@article{Rocha2019TerlipressinAA,
  title={Terlipressin as a first choice in septic shock-not yet.},
  author={Daniel Lima Rocha and Fabio Tanzillo Moreira and Ary Serpa Neto},
  journal={Journal of thoracic disease},
  year={2019},
  volume={11 Suppl 9},
  pages={
          S1384-S1386
        }
}
Sepsis, a dysregulated host response to infection leading to organ dysfunction, and septic shock, a subset of patients with sepsis, cardiovascular collapse and cellular and metabolic dysfunction, are still major healthcare problems (1). Despite significant progresses in intensive care medicine, septic shock remains associated with high morbidity and mortality (1), and all efforts should be made to improve the outcomes of this group of patients. Patients presenting to the intensive care unit… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 15 REFERENCES

Vasopressin in Vasodilatory Shock.

  • Critical care clinics
  • 2019
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial

Zimeng Liu, Juan Chen, +22 authors Xiangdong Guan
  • Intensive Care Medicine
  • 2018
VIEW 1 EXCERPT

A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.

  • Liver international : official journal of the International Association for the Study of the Liver
  • 2017
VIEW 1 EXCERPT